![](/img/cover-not-exists.png)
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune‐related adverse effect: A case report
Edahiro, Ryuya, Ishijima, Mikako, Kurebe, Hiroyuki, Nishida, Kohei, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yano, Yukihiro, Mori, MasahideJournal:
Thoracic Cancer
DOI:
10.1111/1759-7714.13065
Date:
April, 2019
File:
PDF, 400 KB
2019